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A B S T R A C T
Background: Major depression and bipolar disorders aggregates in families and are linked with a wide range of
neurobiological abnormalities including cortical gray matter (GM) alterations. Prospective studies of individuals
at familial risk may expose the neural mechanisms underlying risk transmission.
Methods: We used voxel based morphometry to investigate changes in regional GM brain volume, over a seven-
year period, in 37 initially healthy individuals having a mono- or di-zygotic twin diagnosed with major de-
pression or bipolar disorder (high-risk group; mean age 41.6 yrs.) as compared to 36 individuals with no history
of aﬀective disorders in the index twin and ﬁrst-degree relatives (low-risk group; mean age 38.5 yrs.).
Results: Groups did not diﬀer in regional GM volume changes over time. However, independent of time, high-
risk twins had signiﬁcantly greater GM volumes in bilateral dorsal anterior cingulate, inferior frontal gyrus and
temporoparietal regions as compared to low-risk twins. Further, individuals who developed an aﬀective disorder
at follow-up (n = 12), had relatively the largest GM volumes, both at baseline and follow-up, in the right dorsal
anterior cingulate cortex and right inferior frontal cortex compared to high- and low-risk twins who remained
well at follow-up.
Conclusion: This pattern of apparently stable grater regional GM volume may constitute a neural marker of an
increased risk for developing an aﬀective disorder in individuals at familial risk.
1. Introduction
Major depressive disorder (MDD) and bipolar disorder (BD) have
consistently been linked with neurophysiological impairments related
to cognitive and executive function, and emotional processing (Gotlib
and Joormann, 2010), with numerous neuroimaging studies reporting
structural and functional abnormalities in the brain regions subserving
these processes (Hamilton et al., 2013; Peng et al., 2016; Wise et al.,
2016). The available neuroimaging data in depressed patients, reveal
highly heterogeneous and widespread brain abnormalities, involving
prefrontal, as well as temporal and subcortical brain structures. Studies
of gray matter (GM) changes in various groups of MDD and BD patients
have reported smaller volume in hippocampus, anterior cingulate
cortex (ACC), and multiple regions in prefrontal cortex (PFC) such as
subgenual and orbitofrontal cortex, and dorsolateral and dorsomedial
PFC (Bora et al., 2012; Lai, 2013; Lorenzetti et al., 2009).
Studies in MDD patients investigated immediately after their ﬁrst
episode and in medication-naïve patients often report conﬂicting ﬁnd-
ings compared with studies in medicated and chronically ill patients
(Peng et al., 2016). For instance, no volumetric diﬀerences in patients
in the early course of depression relative to non-depressed participants
were observed in amygdala, hippocampus or orbitofrontal cortex (OFC)
(Arnone et al., 2012; Hastings et al., 2004; McKinnon et al., 2009;
Pizzagalli et al., 2004; van Eijndhoven et al., 2009). Other studies re-
ported larger amygdala volume (Frodl et al., 2003, 2002) or larger
cortical volume, density and thickness in ACC (Adler et al., 2007; van
Eijndhoven et al., 2013; Zhao et al., 2014), or OFC and dorsolateral PFC
(Qiu et al., 2014). In conclusion, the described heterogeneity in the
neuroimaging ﬁndings may well reﬂect the eﬀects of distinct clinical
factors such as chronicity, disorder progression, frequency of depres-
sion episodes, and/or medical treatment.
Studies in healthy individuals at increased risk for aﬀective
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disorders are instrumental in identifying dysfunctional systems that
precede onset of the disorders without being cofounded by clinical
factors. Having a ﬁrst-degree relative with an aﬀective disorder is a
strong predictor of increased risk for depression (Gottesman et al.,
2010; Oquendo et al., 2013; Sullivan et al., 2000). Our group has pre-
viously found reduced hippocampal volumes (Baaré et al., 2010) in
healthy co-twins of patients with MDD (n = 59) as compared to healthy
twins with no family history of aﬀective disorders (n = 53). In line with
this ﬁnding, Amico et al. (2011) reported smaller right hippocampal
gray matter volumes in individuals with a positive family history for
MDD compared to both matched controls with no family history and
MDD patients. They further reported gray and white matter volume
reductions in dorsolateral PFC in healthy high-risk individuals com-
pared to the low-risk controls. MDD mothers and their healthy daugh-
ters showed reduced volume and cortical thickness in temporoparietal
regions and the dorsomedial PFC compared to matched healthy mo-
thers and their healthy daughters (Ozalay et al., 2016). In a study in-
vestigating a group of high-risk young adults at baseline and following a
2-year period, Papmeyer et al. (2015) found reduced cortical thickness
in the right parahippocampal and fusiform gyrus across both time
points. However, contrasting previous ﬁndings of reduced volume and
thickness, Romanczuk-Seiferth et al. (2014) reported grater GM volume
in bilateral amygdala and hippocampus, and left dorsolateral PFC in
healthy ﬁrst-degree relatives of MDD patients compared to matched
participants with no family history of psychiatric disorders. Peterson
et al. (2009) observed both cortical thickening in subgenual, medial
OFC, and anterior and posterior cingulate gyrus and cortical thinning
across the lateral surface of the right cerebral hemisphere in children
and grandchildren of depressed individuals compared to age matched
individuals with no family risk of aﬀective disorders.
The present longitudinal high-risk study investigated possible re-
gional brain diﬀerences in GM volume in healthy co-twins of patients
with MDD or BD as compared to healthy co-twins with no family his-
tory of aﬀective disorders over a seven-year follow-up period. MDD and
BD show genetic overlap (McGuﬃn et al., 2003; Smoller et al., 2013)
and 10–15% of individuals with an index diagnosis of depression will
subsequently develop a bipolar disorder (Kessing et al., 2017). We
therefore combined relatives to MDD and BD to reveal gray matter
changes related to increased risk in a continuum of aﬀective disorders.
Participants were part of a larger longitudinal study (n = 234) on de-
mographic and clinical risk markers for aﬀective disorders, where we
initially showed that increased aﬀective symptoms, neuroticism and
severe life events (Vinberg et al., 2013a), and impaired executive
function and attention (Vinberg et al., 2013b) at baseline were pre-
dictive of subsequent onset of an aﬀective disorder. Here we used voxel
based morphometry to test the hypothesis that high- and low-risk
participants will show a diﬀerential temporal development of regional
GM volume in brain regions critically implicated in in MDD and BD i.e.
PFC, ACC and hippocampus. We further expected that longitudinal
changes in GM volume in these regions would be most prominent in
those individuals who developed an aﬀective disorder during the 7-
years follow-up.
2. Methods
2.1. Participants
73 healthy MZ and DZ twins, with no diagnosis of aﬀective disorder
prior to the baseline investigation, were included in the current high-
risk structural MRI study. The participants were scanned at baseline and
following a period of 7.1 ± 1.2 years (mean ± SD). The baseline scan
took place between June 2003 and June 2004 and the follow-up scan
between May 2011 and June 2012. All participants were recruited from
a larger high-risk study (n = 234) on demographic and clinical risk
markers for developing depression (Christensen et al., 2007). At base-
line, 174 participants out of the 234 participants took part in the MRI
investigation (for details please see Baaré et al., 2010). Of these 125
participants were considered suitable for follow-up and 49 participants
were excluded due to: arterial malformations (n = 3), hypertension,
diabetes, epilepsy, head trauma or previous chemotherapy (n = 30) or
a family history of psychiatric illness other than MDD or BD (n = 16).
Of the 125 participants invited for the follow-up MRI scan 7 years later,
85 agreed to participate and 73 of them were scanned. The 73 included
participants had a co-twin diagnosed and treated for either MDD or BD
in a psychiatric hospital setting (high-risk twins, n = 37, 27 relatives of
MDD and 10 of BD patients), or no history of aﬀective disorders or other
severe psychiatric illness in ﬁrst-degree relatives (low-risk twins,
n = 36).
The high- and low-risk twins were identiﬁed through record linkage
between the nation-wide Danish Twin Registry, the Danish Psychiatric
Central Research Register and the Danish Civil registration system.
Low-risk twins were matched for age, sex and zygosity with the high-
risk twins. None of the included twins had a record in the Danish
Psychiatric Central Research Register. All participants underwent a
clinical interview using Schedules for Clinical Assessment in
Neuropsychiatry (SCAN 2.1) (Wing et al., 1990) to ascertain that they
did not have a personal history of aﬀective disorders or severe de-
pression episodes, schizoaﬀective disorders or schizophrenia, or any
severe organic brain disease preventing compliance with the study
protocol. The participants were further enquired about lifetime family
psychiatric history based on the Brief Screening for Family Psychiatric
History questionnaire (Weissman et al., 2000). The zygotic status was
obtained from the Danish Twin Registry, which records the zygosity of
same-sex twins based on mailed questionnaires.
Out of the 73 participants investigated over the follow-up period, 12
had an onset of aﬀective disorder during follow-up (10 from the high-
risk group and two from the low-risk group). The time of onset was in
average 1141 (± 758) days before the follow-up investigation, with
diagnoses categorized according to the International Classiﬁcation of
Diseases (ICD-10) as follows: moderate (n = 3; ICD 32.1) or severe
depressive episode (n = 5; ICD 32.2), panic disorder (n = 1; ICD 41),
prolonged depressive reaction (n = 1; ICD 43.21), and mixed anxiety
and depressive reaction (n = 2; ICD 43.22). When comparing the 73
participants with the 161 participants from the initial cohort that were
not included, the included group had a statistically signiﬁcant lower
mean age (40.6 vs. 45.7 years, p = 0.003), higher education level (13.6
vs. 12.4 years, p = 0.005), and a lower percentage of high-risk in-
dividuals (50.7% vs. 67%). Groups did not statistically signiﬁcant diﬀer
in sex distribution, zygosity and other clinical measurements.
The study was conducted in accordance with the Declaration of
Helsinki and was approved by the Danish Ministry of Health and The
Danish Regional Scientiﬁc Ethical Committee (KF-12-122/99 and KF-
01-001/02), and the Data Inspection Agency. Written informed consent
was obtained from all participants.
2.2. Demographic, socio-economic and clinical assessment
The participants underwent clinical interviews using Schedules for
Clinical Assessment in Neuropsychiatry (SCAN 2.1) (Wing et al., 1990)
performed by a trained psychiatrist (MV). At baseline, all participants
were rated with the 17-item Hamilton (HamD) rating scale (Hamilton,
1980), self-rating of psychopathology using the 21-item Beck Depres-
sion Inventory (BDI-21) (Beck et al., 1961), and personality traits in-
cluding neuroticism using the Eysenck Personality Questionnaire (EPQ)
(Eysenck and Eysenck, 1975), the number of severe lifetime life events
(prior LEs), (Kendler et al., 1995) and lifetime family psychiatric history
based on the Brief Screening for Family Psychiatric History ques-
tionnaire (Weissman et al., 2000). Participants were asked to ﬁll in the
BDI-21 questionnaire every six-months, sent to them by mail, to
monitor if they developed an aﬀective disorder. Moreover, they an-
nually ﬁlled in a questionnaire assessing experienced life events in the
preceding 12 months, and a cumulative value during the entire follow-
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up period was calculated (follow-up LEs). The 7-year follow-up as-
sessments were conducted from January 2010 to May 2012. The as-
sessment involved a telephone interview and a SCAN interview was
performed in case the participants had: 1) any contact to a psychologist
or psychiatrist, 2) been on sickness leave because of personal problems,
3) been prescribed any psychopharmacological medicine, or if 4) their
answers in the depression questionnaires raised a suspicion of onset of
psychiatric disorder, or 5) if they were listed with a ﬁrst psychiatric
diagnosis in the Danish Psychiatric Central Research Register during the
follow-up period. For detailed descriptions please see (Christensen
et al., 2007; Vinberg et al., 2013a).
The discordance time was calculated as the number of years be-
tween the date of the MRI follow-up investigation of a healthy high-risk
twin and the date the ill co-twin was diagnosed with either MD or BD.
2.3. Image acquisition protocol
Baseline and follow-up MRI brain scans were performed on the same
3 Tesla MR scanner (Siemens Trio, Erlangen, Germany) using an eight-
channel head array coil. Compatible MPRAGE T1 structural images
were acquired at baseline and follow-up. Image acquisition
settings—Baseline: TR = 1540 ms, TE = 3.93 ms, FA = 9°, matrix
256 × 256, 192 slices 1 × 1 × 1 mm voxels; Follow-up:
TR = 1550 ms, TE = 3.04 ms, FA = 9°, matrix 256 × 256, 192 slices,
1 × 1 × 1 mm voxels, acquisition time 6.32 min.
2.4. Image processing
A good image quality at acquisition time was ascertained by visual
inspection of all individual images. Using Voxel Based Morphometry
(VBM), (Ashburner and Friston, 2000) the structural T1 images were
preprocessed with the Computational Anatomy Toolbox (CAT12 r930)
according to standard procedure. The CAT12 toolbox was implemented
in SPM12 (www.ﬁl.ion.ucl.ac.uk/spm), which was run on MATLAB
R2015a (The MathWorks, Inc., Natick, Massachusetts, United States).
Shortly, during the automatized longitudinal processing stream in
CAT12, baseline and follow-up T1 images were rigidly realigned to
correct for diﬀerences in head position within-subject and a subject
speciﬁc mean image was calculated and used as reference in a sub-
sequent realignment of the baseline and follow-up T1 images. The
realigned images were segmented in GM, white matter (WM) and cer-
ebrospinal ﬂuid (CSF) and corrected for signal inhomogeneities with
regard to the reference mean image (bias correction). Resulting GM and
WM tissue images were used to estimate between-subject spatial nor-
malization deformation ﬁled using the high dimensional Diﬀeomorphic
Anatomic Registration Through Exponentiated Lie Algebra (DARTEL)
warping algorithm (Ashburner, 2007). Resulting deformation ﬁelds
were then applied to the individual bias-corrected tissue images at both
acquisition time points. The resulting DARTEL normalized images were
realigned again to the mean DARTEL normalized image to account for
residual segmentation eﬀects. To compare GM volume, DARTEL
warped tissue images were multiplied i.e. modulated by the linear and
non-linear components of the Jacobian determinant derived from the
deformation ﬁelds. Finally, the resulting GM and WM segmentations
were smoothed using a full-with to half maximum Gaussian smoothing
kernel of 6 mm in all directions (Shen and Sterr, 2013).
The quality of the segmentations, within subject warping, and
spatial normalization was ascertained through visual inspection of all
individual images. We also checked for the sample homogeneity and
identiﬁed outliers by visualizing the correlation values between all in-
dividual GM segmentations within each group using a boxplot and
correlation matrices as implemented in the CAT12 software. We further
calculated the individual GM, WM and CSF volumes in native space,
total brain volume (TBV = GM+WM), and total intracranial volume
(TIV) calculated based on tissue segmentations (Malone et al., 2015) to
correct for diﬀerences in brain size and intracranial capacity. A mean
T1 image was calculated by averaging bias and noise corrected DARTEL
normalized T1 images across all subjects using a 7th degree sinc in-
terpolation for delineating volumes-of-interest (see below).
2.5. Deﬁnition of the volume of interest
Based on our a priori hypothesis, we initially limited our statistical
search to a VOI that included bilateral PFC, ACC and hippocampal
formation. The VOI was deﬁned on the normalized study mean T1
image using FSLView 4.0.1. The ACC (29,524 voxels) and PFC
(676,492 voxels) regions of interest (ROIs) were delineated bilaterally
by editing cortical maps, thresholded at 30%, provided by the Harvard-
Oxford cortical structural Atlas implemented in FSLView (Desikan
et al., 2006). The PFC comprised the cortical regions anterior to the
precentral sulcus: superior, middle and inferior frontal gyri, the frontal
medial cortex and subgenual cortices and the frontal poles. The hip-
pocampal formation (9916 voxels) was delineated bilaterally as de-
scribed in Maller et al. (2006). A VOI mask was constructed by com-
bining the three a priori ROIs. We visually veriﬁed that the VOI mask
had a good ﬁt with all individual spatial normalized T1 images and
tissue maps.
2.6. Statistical analysis
2.6.1. Demographic and clinical variables
Group diﬀerences between high- and low-risk groups were assessed
using the SPSS 20 statistical software Sciences (IBM, Armonk, New
York, United States). Continuous data (HamD, BDI-21, neuroticism,
years of education, prior-LEs and follow-up LEs were checked for de-
viation from the normal distribution using the Shapiro-Wilk test. Group
diﬀerences were assessed using either t-tests for normally distributed
data, or non-parametric Mann-Whitney U tests when signiﬁcant de-
viations from normality present. Pearson's chi-square tests were used
for categorical demographic and socio-economic data (sex, zygosity,
salary and employment data). We also used Mann-Whitney U tests to
evaluate diﬀerences in aﬀective symptoms between twins diagnosed
with an aﬀective disorder at follow up (n = 12) and high-risk twins that
remained well (n = 26).
2.6.2. Voxel-wise analyses
All statistical models were implemented in SPM12 using the in-
dividual modulated segmentations with a 0.1 threshold masking level,
controlling for age, sex and TIV (Peelle et al., 2012) and adjusting for
non-stationarity.
We ﬁrst tested our hypothesis that high- and low-risk participants
will show diﬀerential temporal development of regional GM volume in
brain regions critically implicated in in MDD and BD i.e. PFC, ACC and
hippocampus. For this we used a repeated measure 2-by-2 factorial
model, testing for diﬀerences in regional GM volume changes over time
between low and high-risk groups (group-by-time interactions), as well
as testing for main eﬀects of risk group (between-subject factor: low-
risk vs. high-risk) and time (within-subject factor: baseline vs. follow-
up). Second, we investigated whether the twins diagnosed at follow-up
with an aﬀective disorder showed a diﬀerential pattern of GM volume
changes compared to the high-risk and low-risk twins that remained
well. In an analog model, we therefore split the group factor in three
levels (diagnosed, high-risk well and low-risk well) and computed an F-
test for group diﬀerences. Upon signiﬁcant ﬁndings, we computed be-
tween groups t-tests (n = 6). The search volume in the ﬁrst and second
model was initially conﬁned to the generated VOI mask. We subse-
quently explored eﬀects across the entire brain. We applied a cluster-
forming threshold of p < 0.001 uncorrected (Eklund et al., 2016).
Clusters were considered signiﬁcant at p < 0.05 after correction for
multiple comparison using the Family-Wise Error (FWE) method.
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2.6.3. Planned follow-up analyses
Prompted by the results from testing the main hypothesis (ﬁrst
analysis described above), we performed several follow-up analyses in
analog models using a statistical search volume limited to the clusters
showing signiﬁcant GM volume diﬀerences between the high and low-
risk groups. First, we tested whether the observed group diﬀerences
pertained participants with MDD probands only (n = 27). Second, we
investigated whether observed volume diﬀerences were speciﬁc to GM
by testing for possible white matter volume diﬀerence in an analog
model. Third, we tested if observed signiﬁcant eﬀects remained after
additionally controlling for education level. Fourth, we investigated if
observed diﬀerences were anatomical speciﬁc by using TBV instead of
TIV as covariate in models. Fifth, we tested whether observed GM vo-
lume diﬀerences were independent of the clinical factors found to be
predictive for disease onset e.g. HamD, BDI-21, neuroticism, prior LEs,
and follow-up LEs. Sixth, we explored for possible risk group-by-zyg-
osity interactions, and main eﬀect of zygosity. Seventh, within the high-
risk group, we explored for possible correlations between regional GM
volume change and discordance time. The signiﬁcance threshold for the
follow-up analyses was the same as for the main voxel-wise analyses
(see above).
3. Results
3.1. Demographic, socio-economic and clinical measurements
The distribution of age, sex, zygosity and the time between baseline
and follow-up measurements did not diﬀer signiﬁcantly between the
high- and low-risk groups (Table 1). The high-risk twins had a sig-
niﬁcantly lower level of education and salary status, and showed higher
rates of subclinical aﬀective symptoms and a greater number of aver-
sive lifetime events (Table 1) in accordance with previous reports from
the larger cohort from which current participants were recruited
(Christensen et al., 2007). There were no statistically signiﬁcant dif-
ferences in aﬀective symptoms between high-risk twins with a co-twin
diagnosed with MDD or BD, respectively. Twins diagnosed with an af-
fective disorder at follow-up had signiﬁcantly higher BDI-21 ratings
(p = 0.019) compared with twins who remained well. The other tested
aﬀective symptoms did not diﬀer signiﬁcantly between these groups.
3.2. Voxel-wise analysis
We did not observe any signiﬁcant risk group-by-time interactions
within the predeﬁned VOI mask or at the whole brain level, indicating
that high-risk and low-risk groups did not diﬀer in the temporal de-
velopment of GM volume. However, when comparing high-risk and
low-risk twins we found a main eﬀect of risk within the a priori VOI,
with high-risk twins having greater GM volumes in bilateral ACC and
inferior frontal gyrus (IFG) clusters as compared to low-risk twins
(Fig. 1, Table 2). Additionally, exploratory whole-brain analyses
showed that, independent of time, high-risk twins compared to low-risk
twins had signiﬁcantly greater GM volumes in left supramarginal and
right angular gyri and lower GM volumes in a cerebellum cluster
(Table 2). We also found a main eﬀect of time at the whole brain level,
with regional decreases in dorsomedial PFC GM volume and regional
increases in GM volume in several right hemisphere posterior cortical
regions and left ventral striatum at follow-up compared to baseline (see
Table 2).
The ANOVA model where the group factor had three levels (diag-
nosed, high-risk well, and low-risk well), revealed a signiﬁcant main
eﬀect of group in the same bilateral ACC regions where high-risk twins
showed increased GM volume compared to low-risk twins in the pre-
vious two-group comparison (see above). The twins diagnosed with an
aﬀective disorder at follow-up displayed the greatest GM volumes
changes compared to high- and low-risk twins that remained well
(Fig. 1, Table 2). Post-hoc two-group comparisons conﬁrmed the
increased ACC volume in the high-risk twins compared to the low-risk
twins that remained well. In addition, the diagnosed twins showed
larger precuneus compared to the low-risk twins that remained well,
and the low-risk twins further showed higher cerebellar volumes
compared to the high-risk twins that remained well (Table 2).
3.3. Planned follow-up analyses
Follow-up tests restricted to those brain regions for which we found
main group diﬀerences, independent of time, conﬁrmed that all ob-
served regional GM volume group diﬀerences remained statistically
signiﬁcant when including only the high-risk twins with a co-twin di-
agnosed with MDD. We did not ﬁnd a signiﬁcant risk group-by-zygosity
interaction or a main eﬀect of zygosity. Group diﬀerences also re-
mained statistically signiﬁcant when controlling for TBV, education
level, and clinical factors (HamD, neuroticism and lifetime life events)
in three separate analyses. Finally, we found a signiﬁcant main eﬀect of
group in dorsal ACC and right IFG when comparing high-risk partici-
pants with an aﬀective disorder at follow-up with high-risk individuals
who remained well and low-risk participants.
4. Discussion
The current longitudinal high-risk study aimed to characterize dif-
ferences in regional GM brain volume changes between healthy twins
discordant for aﬀective disorders and healthy twins with no familial
history of aﬀective disorders. In contrast to our hypothesis, we did not
Table 1
Risk status, demographic and clinical data at baseline for the initial groups of high-risk
and low-risk twins and for the twins diagnosed with an aﬀective disorder at follow-up.
Bold values represent signiﬁcant group diﬀerences.
Diagnosed High-
risk
Low-
risk
Signiﬁcance high
vs. low risk
Demographic data
Number of
participants
12 37 36
Time between
scans (yrs.)
7.4 (0.9) 7.4 (0.8) 7.2 (0.8) 0.329t
Age (baseline) 39.1 (10.5) 41.6
(11.1)
38.5
(10.7)
0.220t
Sex (m/f) 2/10 15/22 13/23 0.697p
Zygosity (MZ/DZ) 6/6 14/23 16/20 0.633p
Education (yrs.) 12.2 (2.5) 12.8
(2.9)
14.4
(2.5)
0.014t
Employment status 0.095p
Employed 9 32 35
Unemployed 3 5 1
Salary status 0.033p
High earner 1 4 11
Low or medium
earner
11 23 16
Clinical data
HamD baseline 4.1 (3.1) 3.6 (2.2) 1.7 (1.4) 0.000u
BDI-21 baseline 3.3 (2.9) 2.6 (2.9) 1.0 (1.5) 0.004t
BDI-21 follow-up 3.6 (3.8) 2.4 (3.1) 1.2 (1.5) 0.169u
Neuroticism 5.3 (4.5) 4.8 (3.7) 0.011u
Prior LEs 2.4 (1.8) 2.7 (1.7) 1.6 (1.2) 0.000t
LEs follow-up 11.3 (6.0) 11.2
(6.8)
5.3 (4.5) 0.001t
Discordance time 5.8 (5.6) 12.5
(8.5)
Values for the demographic data are mean (SD) or frequency; values for the clinical data
are mean (SD); values for employment and salary status are frequency; t = t-test;
u = Mann-Whitney U test; p = Pearson's chi-square test; m = male; m = female;
MZ = monozygotic; DZ = dizygotic; HamD= Hamilton Depression Scale; BDI-21 = 21-
item Beck Depression Inventory; prior LE = number of previous severe life events. LEs
follow-up = number of LEs during follow-up. Discordance time = number of years at
follow-up between the MRI investigation of a healthy high-risk twin and diagnosis of the
ill co-twin.
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ﬁnd that high-risk twins diﬀered from low-risk twins in regional GM
volume changes over a seven-year follow-up period, within the a priori
volume of interest including PFC, ACC and hippocampal complex or at
the whole brain level. However, we found that independent of time,
high-risk twins had larger GM volumes in bilateral ACC, IFG and tem-
poroparietal regions as compared to low-risk twins. This pattern did not
change when controlling for zygotic group or when considering only co-
twins of probands with MDD. Exploratory analyses revealed that the
twins who developed an aﬀective disorder during follow-up had the
relatively largest right dorsal ACC and right IFG volumes.
Our observation of a statistically signiﬁcant risk group eﬀect and a
lack of risk group by time interactions, suggests that larger GM volumes
observed in the high-risk group occurred at an earlier time point in
development and remained stable over time. To our knowledge, only
one other high-risk cohort was previously investigated over time.
Young adults with a family history of BD were examined at baseline
(average age 21.0 years) and after a 2-year follow-up period (Papmeyer
et al., 2016, 2015). It was found that high-risk individuals who were
diagnosed with MDD at follow-up displayed left IFG thickening relative
to high-risk individuals that remained well (Papmeyer et al., 2015).
Additionally, at both times of investigation, the two high-risk groups
showed reduced cortical thickness compared to matched low-risk par-
ticipants in the right parahippocampal and fusiform gyrus. In the same
cohort, investigation of regional GM volumes in subcortical regions of
interest yielded no signiﬁcant group diﬀerences in GM volume changes
over time or across the two measurement times (Papmeyer et al., 2016).
The ﬁndings in the young adults with a family history of BD suggest
that increased risk and onset of illness is associated with distinct
changes in cortical thickness. These ﬁndings may stand in contrast with
our current data showing bilateral larger IFG volumes at both baseline
and follow-up. These diﬀerences may be attributed to diﬀerences in
sample age, diagnosis of index twin, and GM metrics.
The larger GM volume we observed in the high-risk group was lo-
cated in the dorsal “cognitive” ACC region, which is part of a dis-
tributed attentional network playing a key role in the modulation of
executive functions, error monitoring and motivation (Bush et al.,
Fig. 1. Time independent group diﬀerences between the high-risk, and low-risk groups in regional gray matter volume, adjusted for age, sex and total intracranial volume. Left panels:
Clusters showing increased gray matter volume (FWE corrected p < 0.05) in high-risk > low-risk (yellow > red). Overlaid light green indicate subregions where the gray matter
volume was relatively highest for participants who developed an aﬀective disorder during follow-up (diagnosed > high-risk > low-risk). Right panels: partial regression plots of peak
ACC volumes adjusted for sex and age and total intracranial volume from the high-risk > low-risk analysis (top) and the diagnosed > high-risk > low-risk analyses (bottom).
Abbreviations: R—right, P—posterior, ACC—anterior cingulate cortex. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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2000). This structural change may account for the enhanced functional
response in this region to happy and fearful faces observed in a sub-
sample of the present high-risk twins (Miskowiak et al., 2015). Our
ﬁnding of larger GM volume in this region corroborates previous re-
ports of grater cortical thickness in the dorsal ACC (among other re-
gions showing both thinner and thicker cortex) in healthy individuals at
familial risk for aﬀective disorders (Peterson et al., 2009). In addition,
larger regional GM volumes in high-risk individuals are further sup-
ported by previous reports in ﬁrst-episode treatment-naïve patients
with MDD showing widespread increases in cortical thickness in
frontal, temporal and anterior and posterior cingulate cortex (van
Eijndhoven et al., 2013; Qiu et al., 2014). In comparison with ﬁndings
in high-risk individuals and ﬁrst-episode MDD, meta-analyses across
studies with various groups of MDD patients report GM alterations in
the anterior “aﬀective” ACC division, involved in emotional regulation
e.g. (Lai, 2013).
The greater GM volumes we found in dorsal ACC and right IFG were
stable over the follow-up period with the greatest diﬀerences observed
in individuals that developed an aﬀective disorder. These GM diﬀer-
ences may therefore constitute a vulnerability biomarker for developing
aﬀective disorders. The observed greater GM volumes in temporopar-
ietal cortex were however only associated with high-risk but not with
illness onset. Greater GM volumes in temporoparietal regions may
therefore reﬂect resilience to illness, or may be of compensatory nature
to e.g. oﬀset deﬁcits in cognitive performance observed in these high-
risk twins (Vinberg et al., 2013b). We ﬁnd the latter speculation more
plausible since our high-risk cohort, despite being middle-aged, was
still at elevated risk compared with low-risk individuals. Our long-
itudinal assessment revealed onset of an aﬀective disorder in 10 high-
risk compared to two in the low-risk group during the seven years'
period between measurements. Similar proportions were found in our
larger twin cohort (n = 234, mean age at baseline 39.4 and follow-up
44.8) where 21.2% (n = 31) in the high-risk group vs. 5.7% (n = 5) in
the low-risk group had an onset of aﬀective disorder at the 7 year
follow-up.
The follow-up analysis did not reveal a signiﬁcant eﬀect of zygosity.
It is possible that environmental factors may have contributed more to
the observed diﬀerences than genetic risk factors. In line with such
interpretation are the ﬁnding that high-risk twins had experienced
signiﬁcantly more severe life events compared to the low-risk group
(Table 1) and that the experience of severe life events before baseline
has been shown to be predictive for onset of aﬀective disorder (Vinberg
et al., 2013a).
The neurobiological underpinnings of the observed GM volume
diﬀerences in high-risk and depressed individuals and how these
changes related to functional changes remain unclear. In general, VBM
is not speciﬁc to neural tissue and cannot oﬀer direct information about
the molecular and cellular processes leading to volumetric diﬀerences.
For instance, changes in myelination, cell size and density, vascular-
ization and neuroinﬂammatory processes may aﬀect relaxation times
and therefore voxel intensities of a T1-weighted image (Zatorre et al.,
2012). Future studies are needed to provide a belter insight into the
neurobiological processes mediating the increased risk for aﬀective
disorders.
There are several potential limitations to our ﬁndings. The small
sample of participants (n = 12) that developed an aﬀective disorder at
follow-up resulted in a low statistical power to detect GM volume dif-
ferences between this group and the high-risk and low-risk groups that
remained well. Moreover, the follow-up MRI scan took place 7 years
after the initial baseline assessment which resulted in intersubject dif-
ferences in the time past between disorder onset and follow-up scan.
Since we did not observe any group by time interaction, suggesting that
groups did not develop diﬀerently over time, investigating individuals
an earlier point in time and/or follow individuals over a longer period
of time might have allowed to elucidate possible diﬀerent GM volume
trajectories in high-risk compared to low-risk twins. While we were able
to conﬁrm our ﬁndings in relatives of MDD only, our high-risk sample
with an index twin diagnosed with BD was too small (n = 10) to be able
to detect subtle diﬀerences between relatives to BD and MDD patients.
Caution should therefore be applied when interpreting the current
ﬁndings in the context of relatives to BD patients. Further, we did not
corroborate hippocampus reduction as a biomarker for risk, or the ne-
gative whole-brain VBM ﬁndings in our previous study performed in a
larger cohort (59 high-risk and 53 low-risk) that included the baseline
scans of the participants that took part in the current study (Baaré et al.,
2010). These diﬀerences may be accounted by several factors. The
Baaré et al. study performed an ROI analysis comparing mean hippo-
campal volume in a larger and more homogenous group of co-twins of
unipolar patients only. In addition, the Baaré et al. study did not use a
VOI approach for the prefrontal cortex in the VBM analysis and com-
pared the groups only at baseline. Lastly, ﬁndings related to changes
over time independent of risk group may be confounded by scanner and
MRI sequence updates, despite adjusting for the time factor in the
statistical models.
In conclusion, unaﬀected twins discordant for aﬀective disorders
showed greater GM volumes in ﬁve bilateral cortical regions located in
Table 2
Regional gray matter volume diﬀerences from the VBM analyses.
Region Side x y z Z-stat
voxel
Voxels
in
cluster
Cluster
pFWE
Main eﬀect of risk group
High-risk > low-risk (t-test)
Anterior
cingulate
R 10 30 24 5.3 3286 < 0.001
(VOI)
L −4 26 30 4.5
Inferior frontal
gyrus
R 40 30 16 4.6 846 0.047
(VOI)
L −36 18 24 4.6 958 0.020
(VOI)
Angular gyrus R 56 −58 30 4.5 991 0.026
Supramarginal
gyrus
L −56 −47 38 4.4 2000 < 0.001
Low-risk > high-risk (t-test)
Cerebellum R 10 −62 −14 4.7 3076 < 0.001
Diagnosed vs. high-risk well vs. low-risk well (F-test)
Anterior
cingulate
R 10 30 24 5.0 1251 0.001
(VOI)
L −2 28 22 4.2 1292 0.001
(VOI)
High-risk well > low-risk well (t-test)
Anterior
cingulate
R 10 30 24 5.2 3835 < 0.001
(VOI)
L −2 28 22 4.7
Diagnosed > low-risk well (t-test)
Precuneus R 8 −54 66 4.5 903 0.04
Anterior
cingulate
R 8 20 36 4.2 693 0.056 n.s.
Low-risk well > high-risk well (t-test)
Cerebellum R 8 −64 −12 4.6 2707 < 0.001
Main eﬀect of time
Follow-up > baseline (t-test)
Ventral striatum L −4 8 −14 6.14 4923 < 0.001
Inferior
temporal gyrus
R 52 −64 −8 5.61 2153 < 0.001
Temporal pole R 54 12 −16 5.12 1198 < 0.001
Lingual gyrus R 12 −54 0 5.03 1403 < 0.001
Precuneus R 6 −46 18 4.51 575 0.028
Baseline > follow-up (t-test)
Dorsomedial
prefrontal cortex
L −4 42 48 4.50 963 0.004
Data shown for regional peaks with coordinates x, y, z in MNI standard stereotactic space,
Z statistics, cluster size in voxels at an extent threshold of p < 0.001 uncorrected and
corrected cluster p. Data from volume of interest analyses are presented with small vo-
lume corrected p values (VOI). Abbreviations: L = left, R = Right, FWE = Family-Wise
Error corrected, n.s. = not signiﬁcant, VOI = volume of interest.
J. Macoveanu et al. NeuroImage: Clinical 17 (2018) 786–793
791
ACC, IFG and temporoparietal regions. These diﬀerences were stable at
both times of investigation and appeared more pronounced in partici-
pants who developed an aﬀective disorder at follow-up. This pattern in
gray matter volume diﬀerences may be indicative of an increased vul-
nerability to aﬀective disorders indexing as a potential endophenotype.
Further studies in younger high-risk participants with a longer follow-
up period may be more sensitive in diﬀerentiating between GM changes
related to risk and GM changes predictive of illness onset.
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